amyotrophic lateral sclerosis therapy (University of Iowa/Targeted Genetics)

N/A

Report date: 2025/03/14 20:00:48
NME

Base Information

Drug Nameamyotrophic lateral sclerosis therapy (University of Iowa/Targeted Genetics)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionNADPH oxidase modulators
TargetsNADPH oxidase
Therapy Area/IndicationsAmyotrophic Lateral Sclerosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesThe University Of Iowa
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesThe University Of IowaArmata Pharmaceuticals Inc
Active IndicationsN/A
Inactive IndicationsAmyotrophic Lateral Sclerosis

Other Information

ATC CodeN/A
Related LinksN/A